Navigation Links
Quark Pharmaceuticals to Present at American Society for Pharmacology and Experimental Therapeutics Annual Meeting
Date:4/20/2009

FREMONT, Calif., April 20 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference (RNAi)-based therapeutics, today announced that James D. Thompson, Ph.D., Vice President, Pharmaceutical Development, will give a presentation on Tuesday, April 20 at this year's American Society for Pharmacology and Experimental Therapeutics (ASPET) Annual Meeting, which is taking place from April 18-22, 2009 in New Orleans.

Dr. Thompson's presentation will be part of a session titled "Discovery and Development of Oligonucleotide Therapeutics," which is sponsored by ASPET's Divisions for Drug Discovery, Drug Development & Regulatory Affairs and Molecular Pharmacology. His talk will be on the past, present, and future of oligonucleotide therapeutics. Other leaders in RNAi will also present during the session including: Pamela A. Pavco, Vice President of Pharmaceutical Development at RXi Pharmaceuticals (topic: Special issues in the discovery and development of RNAi therapeutics); Christina Gamba-Vitalo, Senior Director Preclinical Development at Alnylam Pharmaceuticals (topic: Progress in developing siRNAs as drugs); and Patrick L. Iversen, Senior Vice President of Strategic Alliances and former Senior Vice President of Research and Development at AVI BioPharma (topic: Pharmacokinetics of oligonucleotide therapeutics).

Daniel Zurr, Ph.D., President and Chief Executive Officer of Quark, said, "We are pleased with Quark's participation in this session alongside respected leaders in RNAi development. The invitation reinforces that the drug development industry recognizes Quark's leadership position in siRNA development. Some of the Company's accomplishments include: a number of on-going clinical trials of synthetic siRNAs in various disease indications, status as the first company to administer a synthetic siRNA systemically in humans, an, enabling portfolio of I
'/>"/>

SOURCE Quark Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Quark Pharmaceuticals Announces Poster Presentations at RNAi Europe 2008
2. FDA Approves Quark IND for DGFi, an siRNA Therapeutic Based on Silence Therapeutics Unique Proprietary Chemistry
3. Quark Pharmaceuticals to Participate in 9th Annual Beyond Genome Conference
4. Mpex Pharmaceuticals Names Mark Wiggins Chief Business Officer
5. Anadys Pharmaceuticals to Report First Quarter 2009 Financial Results
6. Sunesis Pharmaceuticals Receives NASDAQ Notification
7. Angiotech Pharmaceuticals, Inc. Announces Conference Call And Webcast
8. XTL Biopharmaceuticals Ltd. Receives Notification of Delisting Determination by NASDAQ Listing Qualifications Panel
9. Accera, Inc. Launches Neuera Pharmaceuticals, Inc.
10. Poniard Pharmaceuticals to Present Final Data from Picoplatin Phase 1 Clinical Trials at American Association for Cancer Researchs 100th Annual Meeting
11. Zenobia Therapeutics Successfully Completes Initial Phase of Its Service Agreement With Syntonix Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 24, 2014   BioLife Solutions , ... manufacturer and marketer of proprietary clinical grade hypothermic ... precision thermal shipping products for cells and ... will hold its 2015 Annual Meeting of Stockholders on ... the expected date for the Annual Meeting represents a ...
(Date:12/24/2014)... Boston, MA (PRWEB) December 23, 2014 ... presentation, Dr. James L. Sherley, director of the Adult ... attention on an often overlooked and under appreciated unique ... “Asymmetric Self-Renewal by Distributed Stem Cells: Misunderstood in the ... his message to congress participants. He gave the ...
(Date:12/24/2014)... New York (PRWEB) December 23, 2014 According ... the Long Island Affiliate of ITRA Global, the national office ... but steady recovery. This is evidenced by the third ... strong stock market. Low energy costs have held inflation ... The only negative is the housing market remaining soft. , ...
(Date:12/24/2014)... 2014 The report expects global cell ... 2019. It also provides a carefully analyzed data about ... for the market. , Full Copy of Report @ ... global market for cell expansion will keep witnessing growth ... this growth to be driven by rapid technological advancements, ...
Breaking Biology Technology:BioLife Solutions Sets Date for Annual Meeting of Stockholders 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 3
... For purification of microRNA and total RNA from a wide range of animal tissues and cells ... miRNeasy Kits allow purification of total RNA including miRNA or enrichment , ... for , low-throughput RNA purification. The miRNeasy 96 Kit ... , ...
... , ... the global leader in capital asset auction and ... conducting its 50th global Life Sciences / BioPharma , ... for the DoveBid.com Life Sciences / BioPharma practice, and ...
... For low-throughput disruption of a wide range of biological samples , ... , , The ... tissues and cells and plant tissue. , , ... , Disposable probes to help eliminate cross-contamination ...
Cached Biology Technology:miRNeasy Mini Kit and miRNeasy 96 Kit 2miRNeasy Mini Kit and miRNeasy 96 Kit 3World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition 2World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition 3TissueRuptor System 2TissueRuptor System 3
(Date:12/10/2014)... WINSTON-SALEM, N.C. , Dec. 9, 2014  Wake Forest ... medical education building for its School of Medicine. Funding ... a larger capital campaign that will be publicly launched ... will be located in the former 60 series R.J. ... Forest Innovation Quarter. Construction will begin immediately with plans ...
(Date:12/5/2014)... Dec. 4, 2014 Increased emphasis on ... in new testing and inspection technologies. The convergence ... to a range of innovative test solutions. This ... Generation Y, which is generally more inclined towards ... product development strategies of test equipment vendors will ...
(Date:12/3/2014)... As part of our commitment to offering ... to announce the release of a new reader that ... workforce data that they need. The Atlas ... existing readers. Many such devices have serious shortcomings when ... Older models force users to navigate numerous complicated steps ...
Breaking Biology News(10 mins):Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4Inception Technologies to Release New Biometric Reader 2
... a simultaneous publication (Science Express, 13th April 2006), ... bruchpilot protein and aided neurobiologists from the European ... the protein's central role in the formation of ... from conventional farfield light microscopy in the fact ...
... processes are affecting southern right whales (Eubalaena australis) in ... team of scientists found a strong relationship between breeding ... Nino in the western Pacific. The results are published ... Southern right whales migrate from the South Atlantic to ...
... researchers for many years has been explained by UK scientists. ... of carbon in the Earth's atmosphere require vitamin B12 to ... why some types needed external sources and others did not. ... discovered that half of all algae have a dependent but ...
Cached Biology News:High-resolution light microscope reveals the fundamental mechanisms of nerve communication 2High-resolution light microscope reveals the fundamental mechanisms of nerve communication 3The secret life of algae 2
... selects single cells, or clusters, with rapid, ... all, a single cell can be targeted, ... collected into the pipette, and automatically transferred ... plate. Quixells unique aspiration and expulsion system ...
... Microarrays designed for genome-wide microRNA expression ... and powerful Paraflo microfluidic on-chip synthesis ... part of our comprehensive microRNA Expression ... The Viruses microRNA Microarray contains ...
... At the forefront of Agilent analytical ... Built-in local area networking (LAN) allows you ... sites--for fast and informed decision making. Just ... has all the flexibility and performance needed ...
The novel and unique HCTplus delivers unmatched information-rich data-dependent LC/MSn data for todays challenge in proteomics and metabonomics work....
Biology Products: